Merck & Co Inc (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021
Corporate Participants:
Peter Dannenbaum — Vice President, Investor Relations
Kenneth C. Frazier — Chairman of the Board and Chief Executive Officer
Robert M. Davis — Executive Vice President, Global Services, and Chief Financial Officer
Dean Y. Li — Executive Vice President and President, Merck Research Laboratories
Michael T. Nally — Executive Vice President and Chief Marketing Officer
Analysts:
Seamus Fernandez — Guggenheim Partners — Analyst
Andrew Baum — Citi — Analyst
Terence Flynn — Goldman Sachs — Analyst
Chris Schott — JPMorgan — Analyst
Louise Chen — Cantor — Analyst
David Risinger — Morgan Stanley — Analyst
Daina Graybosch — SVB Leerink — Analyst
Umer Raffat — Evercore ISI — Analyst
Steve Scala — Cowen — Analyst
Navin Jacob — UBS — Analyst
Gregg Gilbert — Truist — Analyst
Mara Goldstein — Mizuho — Analyst
_________
To read the full earnings call transcript, click here